COMMUNIQUÉS West-GlobeNewswire
-
AdvanCell to present promising clinical trial results of ADVC001, a novel Lead-212-based PSMA-targeted alpha therapy for prostate cancer, at ESMO 2025
13/10/2025 -
Nouscom Presents Positive Phase 2 Results of NOUS-209 Immunotherapy Combined with Pembrolizumab in MSI-H Metastatic Colorectal Cancer Patients Refractory to Anti-PD-1 Therapy, at ESMO 2025
13/10/2025 -
EarlyHealth Group Acquires CYB3R, Gulf’s Fastest-Growing Cybersecurity Firm
12/10/2025 -
DB-OTO Results in the New England Journal of Medicine Showcase Dramatic and Sustained Improvements in Hearing and Speech Perception in Children with Profound Genetic Hearing Loss
12/10/2025 -
HomeInherit Introduces Investment Model Offering Seniors Liquidity Without Leaving Their Homes
12/10/2025
Pages